In this study, the authors investigate the full extent of adverse effects resulting from use of multiple analgesics & their impact on QoL in the lay population.
This special report argues that many patients with chronic pain may not be significantly impacted by psychological factors, and that for those who are, cognitive–behavioral therapy is the treatment of choice.
Is biofeedback an effective intervention for the treatment of chronic low back pain? In this commentary, the authors describe biofeedback for chronic low back pain and summarize current research on biofeedback to address key questions.
This PRISMA systematic review analyzes the efficacy of spinal cord stimulation for treatment of phantom limb pain.
In a study from Toronto Western Hospital (TO, Canada), researchers have conducted an analysis of health care data to measure the time of opioid cessation after prescription following major surgery.
In this interview, Dr Clarke discusses his recent paper in Pain Management, ‘Chronic postsurgical pain and persistent opioid use following surgery: the need for a transitional pain service’.
This article explores the role of sleep as a pathological mechanism to fibromyalgia and the currently available pharmacological treatments for improving sleep in fibromyalgia.
New research from Johns Hopkins Medicine (MD, USA) suggests patients who undergo long-term opioid therapy for pain management of sickle cell disease may fare worse than those who do not.
The mechanisms underlying chronic pain conditions are currently poorly understood. This article considers recent advancements in omics technologies and how this may impact our understanding of the biological pathways involved with chronic pain and ultimately development of effective biomarkers and therapies.
Researchers have found a new neurological mechanism, involving synaptic adhesion molecule neuroligin-2, that appears to contribute to a reduction in pain.
